- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01420614
RadIal Versus Femoral InvEstigation in ST Elevation Acute Coronary Syndrome (RIFLE-STEACS)
RadIal Versus Femoral Randomized InvEstigation in ST Elevation Acute Coronary Syndrome
Study Overview
Status
Intervention / Treatment
Detailed Description
Prospective, randomized, double arm study. The study population will include all consecutive patients presenting with a ST-elevation Acute Coronary Syndrome and candidates for primary percutaneous coronary intervention, who agree and provide written informed consent for the study.
Before arterial stick for percutaneous access, patients will be randomized according to sealed numbered envelopes. Subsequently, arterial access will be obtained and the diagnostic/interventional procedure will be performed according to routine clinical practice, leaving ancillary medications, choice of devices and means of hemostasis at the physician's discretion.
In the randomization process all participating centers will be equally stratified to avoid statistical unbalance.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Modena, Italy, 41124
- Università di Modena e Reggio Emilia
-
Rome, Italy, 00100
- Ospedale Sandro Pertini
-
Rome, Italy, 00100
- Policlinico Casilino
-
Turin, Italy, 10100
- University of Turin, San Giovanni Battista Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Subject is >18 years old with recent acute ST-elevation acute coronary syndrome (STEACS) requiring emergent coronary angiography.
- Patient has no contraindication to percutaneous arterial access by both and transfemoral route.
- Subject has been informed of the nature of the study and agrees to its provisions and has provided written informed consent as approved by the Institutional Review Board/Ethics Committee of the respective clinical site.
- Patient and the treating physician agree that the subject will comply with all follow-up evaluations.
Exclusion Criteria:
- Subject's age is <18 years and he has no acute ST-elevation myocardial infarction (ST elevation of a least 0.1 mV in ≥2 extremity leads or at least 0.2 mV in ≥2 precordial leads).
- Subject has had a recent stroke or TIA (<4 weeks), irrespective of age.
- Patient has an international normalized ratio (INR) > 2.0, or other severe bleeding diathesis
- The patient is pregnant or breastfeeding.
- Known allergies to: aspirin, clopidogrel and ticlopidine, heparin, IIb/IIIa inhibitors, stainless steel, or contrast agent (which cannot be adequately premedicated).
7.Subject is currently participating in an investigational drug or device study that has not completed the primary endpoint or that clinically interferes with the current study endpoints.
8.Prior participation in this study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Radial
group of patients undergoing primary angioplasty by transradial approach
|
diagnostic and interventional procedures by radial artery access
Other Names:
|
|
Active Comparator: Femoral
group of patients undergoing primary angioplasty by transfemoral approach
|
diagnostic and interventional procedures by femoral artery access
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Net Adverse Clinical Event
Time Frame: 30-day
|
Cumulative of cardiac death, myocardial infarction, target lesion revascularization, stroke and bleeding
|
30-day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Net Adverse Clinical Event
Time Frame: 1-year
|
Cumulative of cardiac death, myocardial infarction, target lesion revascularization, stroke and bleeding
|
1-year
|
|
Individual components of NACE
Time Frame: 30-day
|
Cardiac death, Myocardial infarction, Target Lesion revascularization, Stroke, Major Bleeding
|
30-day
|
|
Individual components of NACE
Time Frame: 1-year
|
Cardiac death, Myocardial infarction, Target Lesion revascularization, Stroke, Major Bleeding
|
1-year
|
|
Total procedural and fluoroscopy times for the index procedure
Time Frame: 1 day
|
Comparison of procedural and fluoroscopy times between the two study groups
|
1 day
|
|
Hospital stay
Time Frame: 30-day
|
Days of hospitalization
|
30-day
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ernesto Lioy, MD, Policlinico Casilino
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PC-03ER
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Infirmerie Protestante de LyonRecruitingCoronary Artery Bypass | Coronary Artery Disease(CAD) | Off Pump Coronary Artery Bypass Surgery | Hemodynamic Optimization | Hemodynamic Management | Off Pump Coronary Artery Bypass Graft | Coronary Artery Disease With Need for Bypass Surgery | NoradrenalineFrance
-
Shanghai Bluesail Boyuan Medical Technology Co....Not yet recruitingCoronary Artery Disease | Coronary Artery Calcification | Severe Coronary Artery DiseaseChina
-
Scitech Produtos Medicos SANot yet recruitingCoronary Artery Disease (CAD) | Multivessel Coronary Artery Disease | Complex Coronary Lesions | Calcific Coronary Arteriosclerosis | Small Vessel Ischemic Disease | Stenosis CoronaryBrazil
-
Istanbul Mehmet Akif Ersoy Educational and Training...Bakirkoy Dr. Sadi Konuk Research and Training Hospital; Ege University; Istanbul... and other collaboratorsActive, not recruitingCoronary Artery Disease (CAD) | Coronary Bifurcation Lesion | Left Main Coronary Artery StenosisTurkey (Türkiye)
-
I.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioCompletedCoronary Artery Disease (CAD) | Atherosclerosis of Coronary ArteryItaly
-
EBI Anti Sepsis BVCR2O B.V.Not yet recruitingCoronary Artery Disease (CAD) | Coronary Artery Bypass Graft Surgery(CABG)United States, Netherlands, Belgium, United Kingdom
-
University Medical Centre LjubljanaRecruitingCoronary Artery Disease With Myocardial InfarctionSlovenia
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Shunmei MedicalNot yet recruitingCalcified Coronary Artery Disease | Coronary Arterial DiseasePoland, France, Spain
-
OPCI Core Laboratories LLCNot yet recruitingCoronary Artery Disease (CAD) | Coronary Calcification | Coronary Calcified Disease | Coronary Calcified NodulesUnited States
Clinical Trials on Radial approach
-
Capital Medical UniversityCompletedTransradial Approach, Primary PCI, ST-segment Elevation Myocardial InfarctionChina
-
Capital Medical UniversityCompletedPercutaneous Coronary | Transradial Approach, | Coronary Angiography,China
-
Wonju Severance Christian HospitalCompletedCoronary Artery Disease | Stable Angina | ST-segment Elevation Myocardial Infarction | Unstable Angina | Non-ST Elevation Myocardial Infarction | Ischemic Heart Disease Without AnginaKorea, Republic of
-
Wujin People's HospitalCompletedCoronary Artery Disease | Radial Artery Occlusion | Distal Radial ArteryChina
-
Wonju Severance Christian HospitalCompletedKorean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)Coronary Artery Disease | Radial Artery | PunctureKorea, Republic of
-
Shenzhen People's HospitalRecruitingAcute Coronary Syndrome | Outcome, Fatal | Procedural ComplicationChina
-
Instituto Nacional de Cardiologia Ignacio ChavezCompletedRadial Artery OcclusionMexico
-
Jinling Hospital, ChinaRecruitingAcute Ischemic StrokeChina
-
NYU Langone HealthCompletedCoronary Artery DiseaseUnited States
-
Yonsei UniversitySeverance Hospital; Merit Medical Systems, Inc.CompletedCoronary Artery Disease | Distal Radial Artery | Complex InterventionSouth Korea